Drug Profile
OREX 1038
Alternative Names: OREX-1038Latest Information Update: 26 Sep 2023
Price :
$50
*
At a glance
- Originator University of Bath
- Developer Orexigen Therapeutics; University of Bath
- Class Opioid analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cocaine-related disorders; Opioid-related disorders
Most Recent Events
- 26 Sep 2023 Discontinued - Preclinical for Cocaine-related disorders in USA (unspecified route)
- 26 Sep 2023 Discontinued - Preclinical for Opioid-related disorders in USA (unspecified route)
- 26 Sep 2023 Discontinued for Cocaine-related disorders in United Kingdom (unspecified route)